Cargando…
Viable mouse gene ablations that robustly alter brain Aβ levels are rare
BACKGROUND: Accumulation of amyloid-β (Aβ) peptide in the brain is thought to play a key pathological role in Alzheimer's disease. Many pharmacological targets have therefore been proposed based upon the biochemistry of Aβ, but not all are equally tractable for drug discovery. RESULTS: To searc...
Autores principales: | Toyn, Jeremy H, Lin, Xu-Alan, Thompson, Mark W, Guss, Valerie, Meredith, Jere E, Sankaranarayanan, Sethu, Barrezueta, Nestor, Corradi, John, Majumdar, Antara, Small, Daniel L, Hansard, Melissa, Lanthorn, Thomas, Westphal, Ryan S, Albright, Charles F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988800/ https://www.ncbi.nlm.nih.gov/pubmed/21054826 http://dx.doi.org/10.1186/1471-2202-11-143 |
Ejemplares similares
-
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
por: Meredith Jr., Jere E., et al.
Publicado: (2013) -
Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
por: Wes, Paul D., et al.
Publicado: (2014) -
Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects
por: Toyn, Jeremy H., et al.
Publicado: (2016) -
Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
por: Sankaranarayanan, Sethu, et al.
Publicado: (2015) -
Viable medical waste chain network design by considering risk and robustness
por: Lotfi, Reza, et al.
Publicado: (2021)